Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-10 08:22 am Purchase | 13G | KARUNA THERAPEUTICS INC KRTX | VANGUARD GROUP INC | 2,084,336 7.04% | 2,084,336 (New Position) | View |
| 2022-02-09 09:22 am Sale | 13G | KARUNA THERAPEUTICS INC KRTX | FMR LLC | 4,574,106 15.44% | -90,000 (-1.93%) | View |
| 2022-02-04 4:12 pm Purchase | 13G | KARUNA THERAPEUTICS INC KRTX | BlackRock Inc. BLK | 1,638,617 5.5% | 238,362 (+17.02%) | View |
| 2021-11-12 06:25 am Sale | 13D | KARUNA THERAPEUTICS INC KRTX | PureTech Health LLC | 1,656,564 5.6% | -1,750,000 (-51.37%) | View |
| 2021-04-22 7:22 pm Sale | 13D | KARUNA THERAPEUTICS INC KRTX | ARCH Venture Fund IX L.P. | 2,946,891 10% | -135,744 (-4.40%) | View |
| 2021-04-09 6:02 pm Purchase | 13G | KARUNA THERAPEUTICS INC KRTX | BlackRock Inc. BLK | 1,400,255 4.8% | 26,543 (+1.93%) | View |
| 2021-02-16 12:24 pm Purchase | 13G | KARUNA THERAPEUTICS INC KRTX | PRICE T ROWE ASSOCIATES INC | 1,424,161 5.3% | 1,424,161 (New Position) | View |
| 2021-02-10 06:15 am Purchase | 13D | KARUNA THERAPEUTICS INC KRTX | PureTech Health plc PRTC | 2,406,564 9% | 2,406,564 (New Position) | View |
| 2021-02-08 10:25 am Purchase | 13G | KARUNA THERAPEUTICS INC KRTX | FMR LLC | 4,664,106 17.399% | 762,193 (+19.53%) | View |
| 2021-02-02 3:13 pm Purchase | 13G | KARUNA THERAPEUTICS INC KRTX | BlackRock Inc. BLK | 1,373,712 5.1% | 1,373,712 (New Position) | View |
| 2021-01-19 1:25 pm Sale | 13D | KARUNA THERAPEUTICS INC KRTX | ARCH Venture Fund IX L.P. | 3,082,635 11.5% | -280,237 (-8.33%) | View |
| 2020-08-26 5:15 pm Sale | 13D | KARUNA THERAPEUTICS INC KRTX | PureTech Health LLC | 3,406,564 12.8% | -1,333,333 (-28.13%) | View |
| 2020-05-26 06:23 am Sale | 13D | KARUNA THERAPEUTICS INC KRTX | PureTech Health LLC | 4,739,897 18.1% | -555,500 (-10.49%) | View |
| 2020-01-22 5:38 pm Sale | 13D | KARUNA THERAPEUTICS INC KRTX | PureTech Health LLC | 5,295,397 20.4% | -2,100,000 (-28.40%) | View |
| 2019-12-13 4:56 pm Unchanged | 13D | KARUNA THERAPEUTICS INC KRTX | ARCH Venture Fund IX L.P. | 3,362,872 12.9% | 0 (Unchanged) | View |
| 2019-12-10 09:43 am Purchase | 13G | KARUNA THERAPEUTICS INC KRTX | FMR LLC | 3,901,913 14.999% | 3,901,913 (New Position) | View |
| 2019-07-15 09:24 am Purchase | 13D | KARUNA THERAPEUTICS INC KRTX | ARCH Venture Fund IX L.P. | 3,362,872 14.4% | 3,362,872 (New Position) | View |
| 2019-07-11 4:55 pm Purchase | 13D | KARUNA THERAPEUTICS INC KRTX | PureTech Health LLC | 7,395,397 31.6% | 7,395,397 (New Position) | View |
| 2019-07-03 12:54 pm Purchase | 13D | KARUNA THERAPEUTICS INC KRTX | Sofinnova Venture Partners X L.P. | 1,729,352 7.4% | 1,729,352 (New Position) | View |